Use of CHA2DS2-VASc Score In Patients Without Atrial Fibrillation: Review Of Literature

 Hassan Tahir   Usman Sarwar   Ali Hussain   Muhammad Umer Awan   Sajjad Ahmad   Muhammad Shabbir Ijaz   James Livesay   Raj Baljepally

Abstract

CHA₂DS₂-VASc score is used to predict risk of embolic stroke in patients with atrial fibrillation. Various studies have shown that CHA₂DS₂-VASc score can be used in atrial fibrillation free patients to predict various outcomes. Role of CHA₂DS₂-VASc score has been described to predict outcomes in chronic heart failure with reduced ejection fraction, myocardial infarction, post transcatheter aortic valve implantation, post atrial flutter ablation, and Takotsubo cardiomyopathy. Similarly, CHA₂DS₂-VASc score has been used to predict severity of coronary artery disease, no reflow phenomenon post stenting, contrast induced nephropathy and transradial approach failure.

CHA₂DS₂-VASc score is a simple easy to use tool which can be used in assessing and risk stratifying various cardiovascular and cerebral vascular conditions in the absence of atrial fibrillation.